Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug
Up next
Author


Eli Lilly shares jumped in premarket trade on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts.

You May Also Like
Opinion: Amazon's AI talk is making Wall Street drool, but there seems to be a catch

Opinion: Amazon’s AI talk is making Wall Street drool, but there seems to be a catch

Amazon.com Inc. investors were willing to look past a soft holiday-quarter outlook…
Cardinal Health’s stock falls after company says contract with OptumRx will not be renewed after June

Cardinal Health’s stock falls after company says contract with OptumRx will not be renewed after June

Drug distributor backs fiscal 2024 profit guidance despite end of contract that…
Why Super Micro’s stock is falling after earnings — even as guidance moves higher

Why Super Micro’s stock is falling after earnings — even as guidance moves higher

Super Micro continued to exhibit margin pressure in the latest quarter, reflecting…
Here's a new way to consider value for stocks in the S&P 500

Here’s a new way to consider value for stocks in the S&P 500

Investing and trading are not the same thing. A lot of financial-media…